Studies on recombinant ATP synthase subunits in other mycobacteria provide a framework for understanding potential applications for M. gilvum atpD:
Heterologous expression: Recombinant atpD from M. tuberculosis and M. smegmatis has been expressed in E. coli or mycobacterial vectors for functional assays .
Regulatory elements: The αCTD in M. smegmatis suppresses ATP hydrolysis, a mechanism potentially conserved in M. gilvum .
While M. gilvum is a nonpathogenic, bioremediation-relevant species, its ATP synthase remains understudied.
Biotechnological utility: Recombinant atpD could enable studies on:
Comparative genomics: M. gilvum shares evolutionary traits with pathogenic mycobacteria, including horizontal gene transfer (HGT) events linked to metabolic adaptation .
Structural characterization: No cryo-EM or crystallographic data exist for M. gilvum F-ATP synthase.
Functional assays: ATP hydrolysis/synthesis kinetics of recombinant atpD remain untested.
Evolutionary context: Horizontal acquisition of ATP synthase-related genes in mycobacteria (e.g., moaA1-D1 locus in M. tuberculosis) suggests M. gilvum may harbor unique adaptations.
KEGG: mgi:Mflv_2318
STRING: 350054.Mflv_2318